IL6 and non-small cell lung carcinoma: In summary, our results revealed the important roles of IL-6 and PD1 in influencing T cell exhaustion; furthermore, the combined blockade of IL-6 and PD1 could be a potential therapeutic approach for the immunotherapy of patients with NSCLC.